Table 2.
Details of patients with recurrence-free survival (RFS) events
| Patient number | Trastuzumab | Hormone receptor | T stage | Preoperative lymph node status | RFS, months | Detail of recurrence or cause of death |
|---|---|---|---|---|---|---|
| 1 | yes | negative | 2 | SLNB positive | 49 | LR (ipsilateral chest wall) |
| 2 | yes | negative | 2 | FNA positive | 12 | distant metastasis (brain) |
| 3 | yes | negative | 3 | FNA positive | 14 | distant metastasis (brain) |
| 4 | yes | negative | 2 | SLNB negative | 28 | distant metastasis (lung) |
| 5 | yes | negative | 2 | FNA positive | 38 | secondary cancer (leukemia) |
| 6 | no | negative | 2 | SLNB negative | 91 | CBC |
| 7 | no | negative | 1 | FNA positive | 128 | CBC |
| 8 | no | negative | 2 | SLNB negative | 47 | CBC |
| 9 | no | negative | 3 | FNA positive | 15 | distant metastasis (liver) |
| 10 | no | negative | 2 | SLNB negative | 16 | distant metastasis (lung) |
| 11 | no | negative | 2 | FNA positive | 43 | IBTR + distant metastasis (contralateral axilla) |
| 12 | no | negative | 2 | FNA positive | 34 | IBTR |
| 13 | no | negative | 2 | SLNB negative | 26 | distant metastasis (liver and bone) |
| 14 | no | negative | 1 | FNA positive | 23 | LR (ipsilateral chest wall) + RR (ipsilateral supraclavicular node) |
| 15 | no | negative | 2 | SLN visualization failure | 89 | distant metastasis (lung) |
| 16 | no | negative | 1 | SLNB negative | 30 | RR (ipsilateral axilla) |
| 17 | no | negative | 2 | clinically suspicious | 15 | cause of death unknown |
| 18 | no | negative | 2 | SLNB positive | 44 | secondary cancer (gastric) |
SLNB, Sentinel lymph node biopsy; FNA, fine needle aspirate; LR, local recurrence; RR, regional recurrence; CBC, contralateral breast cancer; IBTR, ipsilateral breast tumor recurrence.